Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,277 publicly listed stocks with a combined market cap of $1.95 Trillion. LTR Pharma Ltd leads the sector with a market cap of $59.81 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.95 Trillion
Companies Listed
1,277
Largest Company
LTR Pharma Ltd
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 751 |
LTR Pharma Ltd
AU:LTP |
$59.81 Million | AU$84.53 Million | Australia | AU$0.47 | +3.33% | -4.12% | 4.96 Million |
| 752 |
OKYO Pharma Ltd ADR
NASDAQ:OKYO |
$59.80 Million | $59.80 Million | USA | $1.59 | -1.85% | -3.64% | 2.23 Million |
| 753 |
ImageneBio, Inc.
NASDAQ:IMA |
$59.67 Million | $59.67 Million | USA | $5.54 | -6.26% | -0.54% | 239.27K |
| 754 |
Pmv Pharmaceuticals Inc
NASDAQ:PMVP |
$59.06 Million | $59.06 Million | USA | $1.11 | -1.77% | -16.54% | 7.51 Million |
| 755 |
NRX Pharmaceuticals Inc
NASDAQ:NRXP |
$58.91 Million | $58.91 Million | USA | $3.15 | +0.96% | -23.36% | 20.73 Million |
| 756 |
Cingulate Inc
NASDAQ:CING |
$58.68 Million | $58.68 Million | USA | $4.79 | +0.63% | -1.03% | 6.17 Million |
| 757 |
Cardiff Oncology Inc
NASDAQ:CRDF |
$58.48 Million | $58.48 Million | USA | $0.86 | +0.52% | +2.06% | 37.82 Million |
| 758 |
Cassava Sciences Inc
NASDAQ:SAVA |
$58.21 Million | $58.21 Million | USA | $1.21 | -6.23% | -20.98% | 10.03 Million |
| 759 |
Synthaverse S.A.
WAR:SVE |
$58.18 Million | zł211.40 Million | Poland | zł2.79 | -1.06% | +0.36% | 917.14K |
| 760 |
Prescient Therapeutics Ltd
AU:PTX |
$56.78 Million | AU$80.25 Million | Australia | AU$0.09 | +3.66% | -9.57% | 23.48 Million |
| 761 |
Fluoguide AS
ST:FLUO |
$55.42 Million | Skr515.00 Million | Sweden | Skr31.50 | +0.96% | -1.87% | 256.94K |
| 762 |
Context Therapeutics Inc
NASDAQ:CNTX |
$55.07 Million | $55.07 Million | USA | $0.60 | -1.30% | +1.20% | 59.54 Million |
| 763 |
Kronos Bio Inc
NASDAQ:KRON |
$53.65 Million | $53.65 Million | USA | $0.88 | +0.00% | +0.00% | 54.09K |
| 764 |
Elicio Therapeutics Inc.
NASDAQ:ELTX |
$53.44 Million | $53.44 Million | USA | $2.80 | -3.78% | -11.11% | 22.17 Million |
| 765 |
Immutep Limited
F:YP1A |
$53.41 Million | €45.69 Million | Germany | €0.31 | -0.64% | -2.52% | 0.00 |
| 766 |
iNtRON Biotechnology Inc
KQ:048530 |
$52.17 Million | ₩76.98 Billion | Korea | ₩2435.00 | +3.84% | -2.99% | 2.13 Million |
| 767 |
Ultimovacs ASA
OL:ULTI |
$52.14 Million | Nkr495.45 Million | Norway | Nkr14.40 | +0.00% | +0.00% | 8.70K |
| 768 |
Lixte Biotechnology Holdings Inc
NASDAQ:LIXT |
$52.05 Million | $52.05 Million | USA | $4.48 | +7.43% | -8.01% | 11.75 Million |
| 769 |
Avecho Biotechnology Ltd
AU:AVE |
$51.94 Million | AU$73.41 Million | Australia | AU$0.02 | +0.00% | -13.64% | 267.96 Million |
| 770 |
FLUOGUIDE A/S DK -1
F:96X |
$51.80 Million | €44.31 Million | Germany | €2.71 | +0.37% | -1.09% | 0.00 |
| 771 |
Arovella Therapeutics Ltd
AU:ALA |
$51.32 Million | AU$72.53 Million | Australia | AU$0.06 | +0.00% | -6.25% | 13.83 Million |
| 772 |
iBio, Inc. Common Stock
NASDAQ:IBIO |
$50.60 Million | $50.60 Million | USA | $1.40 | +0.72% | +0.00% | 23.86 Million |
| 773 |
Klotho Neurosciences, Inc.
NASDAQ:KLTO |
$50.59 Million | $50.59 Million | USA | $0.47 | -10.72% | +13.43% | 161.05 Million |
| 774 |
Mink Therapeutics Inc
NASDAQ:INKT |
$49.29 Million | $49.29 Million | USA | $10.50 | -0.85% | +1.35% | 287.68K |
| 775 |
Edesa Biotech Inc
NASDAQ:EDSA |
$49.23 Million | $49.23 Million | USA | $5.11 | -2.67% | -9.72% | 1.67 Million |
| 776 |
Filana Therapeutics, Inc.
NASDAQ:FLNA |
$48.79 Million | $48.79 Million | USA | $1.01 | +5.21% | +8.35% | 8.42 Million |
| 777 |
Mereo BioPharma Group PLC ADR
NASDAQ:MREO |
$48.79 Million | $48.79 Million | USA | $0.31 | -4.60% | -9.50% | 37.78 Million |
| 778 |
Dogwood Therapeutics, Inc.
NASDAQ:DWTX |
$48.75 Million | $48.75 Million | USA | $1.64 | +3.80% | +6.49% | 1.69 Million |
| 779 |
Cantargia AB
ST:CANTA |
$48.75 Million | Skr452.97 Million | Sweden | Skr1.82 | +0.33% | -4.11% | 12.24 Million |
| 780 |
Bluebird bio Inc
NASDAQ:BLUE |
$48.67 Million | $48.67 Million | USA | $4.97 | +0.00% | +0.00% | 1.25 Million |
| 781 |
Herantis Pharma Oyj
HE:HRTIS |
$48.34 Million | €41.35 Million | Finland | €1.56 | +1.30% | -2.62% | 386.26K |
| 782 |
Instil Bio Inc.
NASDAQ:TIL |
$48.29 Million | $48.29 Million | USA | $7.12 | -0.28% | -1.11% | 296.48K |
| 783 |
Corline Biomedical AB
ST:CLBIO |
$48.24 Million | Skr448.24 Million | Sweden | Skr17.50 | -1.41% | -0.28% | 129.64K |
| 784 |
Immutep Ltd
AU:IMM |
$47.91 Million | AU$67.71 Million | Australia | AU$0.05 | +0.00% | -8.00% | 288.37 Million |
| 785 |
aTyr Pharma, Inc.
NASDAQ:ATYR |
$47.62 Million | $47.62 Million | USA | $0.49 | +1.19% | -2.49% | 32.89 Million |
| 786 |
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV |
$47.33 Million | $47.33 Million | USA | $1.50 | -1.32% | -10.18% | 10.90 Million |
| 787 |
CTCBIO Inc
KQ:060590 |
$47.31 Million | ₩69.81 Billion | Korea | ₩2920.00 | +5.80% | +0.34% | 1.42 Million |
| 788 |
BeyondSpring Inc
NASDAQ:BYSI |
$47.29 Million | $47.29 Million | USA | $1.15 | +1.77% | +6.48% | 680.97K |
| 789 |
Amplia Therapeutics Ltd
AU:ATX |
$47.22 Million | AU$66.73 Million | Australia | AU$0.13 | +4.00% | -3.70% | 14.20 Million |
| 790 |
Raphas Co. Ltd
KQ:214260 |
$47.07 Million | ₩69.45 Billion | Korea | ₩8260.00 | +2.48% | -8.63% | 821.34K |
| 791 |
PENTIXAPHARM HOLDING N AG
XETRA:PTP |
$46.89 Million | €40.11 Million | Germany | €1.91 | -3.05% | -8.41% | 693.39K |
| 792 |
Seres Therapeutics Inc
NASDAQ:MCRB |
$46.77 Million | $46.77 Million | USA | $4.83 | +1.05% | -7.65% | 2.42 Million |
| 793 |
Intervacc AB
ST:IVACC |
$46.58 Million | Skr432.83 Million | Sweden | Skr1.27 | -1.24% | +3.93% | 5.81 Million |
| 794 |
Inovio Pharmaceuticals Inc
NASDAQ:INO |
$46.51 Million | $46.51 Million | USA | $0.68 | +3.20% | -33.63% | 80.08 Million |
| 795 |
IGM Biosciences Inc
NASDAQ:IGMS |
$46.47 Million | $46.47 Million | USA | $1.27 | -2.31% | -0.78% | 3.58 Million |
| 796 |
LAVA Therapeutics NV
NASDAQ:LVTX |
$45.77 Million | $45.77 Million | USA | $1.74 | +0.00% | -3.87% | 2.49 Million |
| 797 |
Mendus AB (publ)
ST:IMMU |
$45.77 Million | Skr425.31 Million | Sweden | Skr6.94 | +0.14% | +2.81% | 626.45K |
| 798 |
Theranexus SA
PA:ALTHX |
$45.64 Million | €39.03 Million | France | €4.30 | +4.62% | +15.75% | 2.07 Million |
| 799 |
Impact BioMedical, Inc.
NYSE MKT:IBO |
$45.54 Million | $45.54 Million | USA | $0.44 | +0.07% | +4.89% | 5.09 Million |
| 800 |
Tscan Therapeutics Inc
NASDAQ:TCRX |
$45.38 Million | $45.38 Million | USA | $0.74 | -1.68% | -12.22% | 20.65 Million |
| 801 |
PanGen Biotech Inc
KQ:222110 |
$44.81 Million | ₩66.12 Billion | Korea | ₩4900.00 | -0.20% | +3.70% | 181.50K |
| 802 |
Metagenomi, Inc. Common Stock
NASDAQ:MGX |
$44.80 Million | $44.80 Million | USA | $1.19 | -2.46% | -2.46% | 4.56 Million |
| 803 |
GenMont Biotech Inc
TW:3164 |
$44.71 Million | NT$1.42 Billion | Taiwan | NT$16.50 | +1.23% | +0.92% | 846.02K |
| 804 |
Karyopharm Therapeutics Inc
NASDAQ:KPTI |
$43.30 Million | $43.30 Million | USA | $1.92 | -72.61% | -72.92% | 35.00 Million |
| 805 |
EyeGene Inc
KQ:185490 |
$43.03 Million | ₩63.49 Billion | Korea | ₩1469.00 | +2.73% | -2.52% | 3.14 Million |
| 806 |
OS Therapies Incorporated
NYSE MKT:OSTX |
$42.96 Million | $42.96 Million | USA | $1.73 | -4.95% | -7.98% | 19.37 Million |
| 807 |
SMS Lifesciences India Limited
NSE:SMSLIFE |
$42.13 Million | Rs3.90 Billion | India | Rs1288.50 | -6.64% | -3.37% | 65.05K |
| 808 |
Sprint Bioscience AB
ST:SPRINT |
$40.88 Million | Skr379.86 Million | Sweden | Skr3.60 | -3.49% | -4.00% | 5.43 Million |
| 809 |
Entropy Neurodynamics Limited
AU:ENP |
$40.41 Million | AU$57.11 Million | Australia | AU$0.04 | +0.00% | +0.00% | 30.64 Million |
| 810 |
Abnova Taiwan Corp
TW:4133 |
$40.16 Million | NT$1.27 Billion | Taiwan | NT$21.05 | +0.72% | -7.27% | 13.50 Million |
| 811 |
Hyperion DeFi, Inc.
NASDAQ:HYPD |
$40.02 Million | $40.02 Million | USA | $2.64 | -0.75% | +0.00% | 6.50 Million |
| 812 |
MINDMAZE THERAPEUTICS HOLDING SA
SW:MMTX |
$39.69 Million | CHF31.39 Million | Switzerland | CHF0.20 | +0.61% | +30.71% | 32.20 Million |
| 813 |
eXoZymes, Inc.
NASDAQ:EXOZ |
$39.43 Million | $39.43 Million | USA | $4.65 | +1.09% | -1.06% | 332.28K |
| 814 |
Gossamer Bio Inc
NASDAQ:GOSS |
$39.23 Million | $39.23 Million | USA | $0.17 | -4.94% | +18.95% | 933.29 Million |
| 815 |
Oncoinvent ASA
OL:ONCIN |
$38.64 Million | Nkr367.23 Million | Norway | Nkr82.00 | -4.21% | -3.76% | 229.37K |
| 816 |
CESSATECH A/S DK -20
F:8GN |
$38.64 Million | €33.05 Million | Germany | €2.00 | -11.50% | -9.09% | 0.00 |
| 817 |
LAVA THERAP. B.V. EO-12
F:4PKB |
$38.54 Million | €32.96 Million | Germany | €1.44 | -6.49% | +5.88% | 28.80K |
| 818 |
OKYO PHARMA LTD SP.ADR/65
F:OK10 |
$38.38 Million | €32.83 Million | Germany | €1.36 | +0.00% | +0.00% | 0.00 |
| 819 |
PDS Biotechnology Corp
NASDAQ:PDSB |
$38.30 Million | $38.30 Million | USA | $0.69 | -1.85% | -2.06% | 6.32 Million |
| 820 |
RenovoRx Inc
NASDAQ:RNXT |
$38.29 Million | $38.29 Million | USA | $0.96 | +1.82% | +12.15% | 4.69 Million |
| 821 |
Vivoryon Therapeutics NV
AS:VVY |
$37.91 Million | €32.42 Million | Netherlands | €1.20 | +4.82% | +2.58% | 1.56 Million |
| 822 |
Naturalendo Tech Co Ltd
KQ:168330 |
$37.44 Million | ₩55.25 Billion | Korea | ₩1750.00 | +1.33% | -4.32% | 357.62K |
| 823 |
FibroGen Inc
NASDAQ:FGEN |
$37.30 Million | $37.30 Million | USA | $9.22 | -5.05% | +5.98% | 925.11K |
| 824 |
Actinium Pharmaceuticals Inc
NYSE MKT:ATNM |
$37.02 Million | $37.02 Million | USA | $1.18 | +0.00% | -7.81% | 4.49 Million |
| 825 |
Xilio Development Inc
NASDAQ:XLO |
$36.86 Million | $36.86 Million | USA | $9.11 | +0.33% | +9.63% | 1.20 Million |
| 826 |
Relief Therapeutics Holding AG
SW:RLF |
$36.33 Million | CHF28.73 Million | Switzerland | CHF2.89 | +0.87% | +3.41% | 379.74K |
| 827 |
OUTLOOK THERAPEUTICS INC
NASDAQ:OTLK |
$36.02 Million | $36.02 Million | USA | $0.98 | -6.10% | -26.02% | 322.85 Million |
| 828 |
Generation Bio Co
NASDAQ:GBIO |
$35.98 Million | $35.98 Million | USA | $5.34 | -6.97% | -4.81% | 2.86 Million |
| 829 |
Veru Inc
NASDAQ:VERU |
$35.95 Million | $35.95 Million | USA | $2.24 | +0.90% | -3.03% | 6.71 Million |
| 830 |
Lite Strategy, Inc.
NASDAQ:LITS |
$35.43 Million | $35.43 Million | USA | $0.96 | -2.40% | -2.85% | 3.95 Million |
| 831 |
Mural Oncology plc
NASDAQ:MURA |
$35.38 Million | $35.38 Million | USA | $2.04 | +0.00% | +0.49% | 4.99 Million |
| 832 |
Atara Biotherapeutics Inc
NASDAQ:ATRA |
$35.19 Million | $35.19 Million | USA | $8.38 | +2.57% | +2.57% | 1.79 Million |
| 833 |
INmune Bio Inc
NASDAQ:INMB |
$34.83 Million | $34.83 Million | USA | $1.75 | -1.13% | +1.74% | 16.86 Million |
| 834 |
Molecure S.A.
WAR:MOC |
$34.65 Million | zł125.89 Million | Poland | zł6.11 | -0.97% | +3.74% | 1.03 Million |
| 835 |
Nutriband Inc
NASDAQ:NTRB |
$34.64 Million | $34.64 Million | USA | $2.85 | -2.06% | -2.73% | 284.81K |
| 836 |
CORESTEM Inc
KQ:166480 |
$34.44 Million | ₩50.82 Billion | Korea | ₩1809.00 | +7.68% | -2.00% | 3.14 Million |
| 837 |
RTA Laboratuvarlari Biyolojik
IS:RTALB |
$34.16 Million | TL1.52 Billion | Turkey | TL3.05 | +1.33% | -10.03% | 685.63 Million |
| 838 |
Cellid Co. Ltd
KQ:299660 |
$34.13 Million | ₩50.36 Billion | Korea | ₩1707.00 | +1.13% | +57.76% | 41.76 Million |
| 839 |
Take Solutions Limited
NSE:TAKE |
$33.87 Million | Rs3.13 Billion | India | Rs21.42 | +4.13% | +3.13% | 8.27 Million |
| 840 |
Mabion S.A.
WAR:MAB |
$33.18 Million | zł120.57 Million | Poland | zł7.46 | +0.54% | +1.77% | 436.89K |
| 841 |
OnKure Therapeutics, Inc.
NASDAQ:OKUR |
$32.79 Million | $32.79 Million | USA | $3.82 | -4.50% | -9.48% | 4.21 Million |
| 842 |
Lipum AB
ST:LIPUM |
$32.76 Million | Skr304.40 Million | Sweden | Skr14.35 | +0.70% | +1.77% | 1.28 Million |
| 843 |
Dyadic International Inc
NASDAQ:DYAI |
$32.75 Million | $32.75 Million | USA | $1.05 | -1.87% | -13.22% | 6.06 Million |
| 844 |
Level Biotechnology
TWO:3118 |
$32.46 Million | NT$1.03 Billion | Taiwan | NT$31.75 | +0.32% | +0.00% | 372.63K |
| 845 |
NovaBay Pharmaceuticals Inc
NYSE MKT:NBY |
$32.22 Million | $32.22 Million | USA | $1.21 | +4.31% | -13.57% | 3.36 Million |
| 846 |
Grace Therapeutics, Inc.
NASDAQ:GRCE |
$32.19 Million | $32.19 Million | USA | $2.08 | +0.48% | -11.49% | 6.55 Million |
| 847 |
Mereo BioPharma Group plc
F:MAH0 |
$31.92 Million | €27.31 Million | Germany | €0.27 | +3.08% | +3.08% | 0.00 |
| 848 |
Genoway
PA:ALGEN |
$31.09 Million | €26.60 Million | France | €2.44 | +0.00% | -1.21% | 319.24K |
| 849 |
GeneReach Biotechnology
TWO:4171 |
$31.08 Million | NT$986.48 Million | Taiwan | NT$17.35 | +3.27% | -10.57% | 8.31 Million |
| 850 |
PolTREG S.A.
WAR:PTG |
$30.80 Million | zł111.92 Million | Poland | zł24.00 | +0.00% | +4.35% | 192.16K |
| 851 |
Estrella Immunopharma Inc.
NASDAQ:ESLA |
$30.71 Million | $30.71 Million | USA | $0.71 | -0.89% | -6.63% | 1.07 Million |
| 852 |
DNA Biomed Solns
TA:DNA |
$30.71 Million | ILA11.45 Billion | Israel | ILA93.00 | -3.13% | -5.49% | 2.71 Million |
| 853 |
MedMira Inc
V:MIR |
$30.46 Million | CA$42.10 Million | Canada | CA$0.06 | -7.69% | -14.29% | 1.32 Million |
| 854 |
Jiangsu Wuzhong Industrial Co Ltd
SHG:600200 |
$30.17 Million | CN¥206.16 Million | China | CN¥0.29 | +0.00% | -9.38% | 993.60 Million |
| 855 |
Apollomics Inc. Class A Ordinary Shares
NASDAQ:APLM |
$30.09 Million | $30.09 Million | USA | $17.25 | -0.61% | -8.56% | 637.80K |
| 856 |
Briacell Therapeutics Corp
NASDAQ:BCTX |
$29.93 Million | $29.93 Million | USA | $3.44 | -5.23% | -7.53% | 3.50 Million |
| 857 |
Arch Biopartners Inc
V:ARCH |
$29.89 Million | CA$41.32 Million | Canada | CA$0.81 | -4.71% | -7.95% | 1.36 Million |
| 858 |
Microbix Biosystems Inc.
TO:MBX |
$29.84 Million | CA$41.25 Million | Canada | CA$0.30 | +1.69% | +0.00% | 633.89K |
| 859 |
Allakos Inc
NASDAQ:ALLK |
$29.74 Million | $29.74 Million | USA | $0.33 | +0.00% | +0.00% | 725.84K |
| 860 |
ProMIS Neurosciences Inc.
NASDAQ:PMN |
$29.53 Million | $29.53 Million | USA | $13.72 | -8.04% | +8.80% | 4.34 Million |
| 861 |
Lantern Pharma Inc
NASDAQ:LTRN |
$29.42 Million | $29.42 Million | USA | $2.63 | -0.75% | -8.36% | 3.24 Million |
| 862 |
Karolinska Development AB ser. B
ST:KDEV |
$29.36 Million | Skr272.85 Million | Sweden | Skr0.29 | +0.00% | +0.00% | 14.10 Million |
| 863 |
Advicenne
PA:ALDVI |
$27.90 Million | €23.86 Million | France | €1.64 | -5.96% | +3.80% | 2.60 Million |
| 864 |
Sangamo Therapeutics Inc
NASDAQ:SGMO |
$27.50 Million | $27.50 Million | USA | $0.07 | +0.00% | +0.00% | 83.11 Million |
| 865 |
Kyntra Bio, Inc.
NASDAQ:KYNB |
$27.24 Million | $27.24 Million | USA | $6.73 | -0.88% | -4.81% | 260.01K |
| 866 |
India Globalization Capital Inc
NYSE MKT:IGC |
$26.91 Million | $26.91 Million | USA | $0.29 | +0.38% | -3.01% | 21.20 Million |
| 867 |
Plus Therapeutics Inc
NASDAQ:PSTV |
$26.64 Million | $26.64 Million | USA | $3.87 | +6.03% | +2.38% | 3.09 Million |
| 868 |
Athira Pharma Inc
NASDAQ:ATHA |
$26.62 Million | $26.62 Million | USA | $7.66 | +10.85% | +25.78% | 1.34 Million |
| 869 |
Cue Biopharma
NASDAQ:CUE |
$26.56 Million | $26.56 Million | USA | $26.84 | -11.71% | -18.89% | 4.04 Million |
| 870 |
Botanix Pharmaceuticals Ltd
AU:BOT |
$26.49 Million | AU$37.44 Million | Australia | AU$0.02 | -5.00% | -17.39% | 294.99 Million |
| 871 |
ABVC Biopharma Inc
NASDAQ:ABVC |
$26.26 Million | $26.26 Million | USA | $1.01 | -6.48% | -15.83% | 3.84 Million |
| 872 |
Renovaro Biosciences Inc
NASDAQ:RENB |
$26.19 Million | $26.19 Million | USA | $1.13 | -8.87% | -20.42% | 65.34 Million |
| 873 |
NUREXONE BIOLOGIC INC.
F:J90 |
$26.15 Million | €22.37 Million | Germany | €0.24 | -1.62% | -19.27% | 10.00K |
| 874 |
LakeShore Biopharma Co., Ltd
NASDAQ:LSB |
$25.84 Million | $25.84 Million | USA | $0.63 | +0.00% | -26.63% | 93.54K |
| 875 |
Actuate Therapeutics, Inc. Common stock
NASDAQ:ACTU |
$25.80 Million | $25.80 Million | USA | $1.11 | -5.13% | -11.90% | 9.44 Million |
| 876 |
Avecho Biotechnology Limited
F:OEZ |
$25.76 Million | €22.04 Million | Germany | €0.01 | +0.00% | +16.67% | 0.00 |
| 877 |
WOOJUNG BIO Inc
KQ:215380 |
$25.76 Million | ₩38.01 Billion | Korea | ₩2280.00 | +3.40% | -10.59% | 1.73 Million |
| 878 |
Isofol Medical AB
ST:ISOFOL |
$25.68 Million | Skr238.66 Million | Sweden | Skr0.85 | +9.13% | +17.27% | 16.84 Million |
| 879 |
Boundless Bio, Inc. Common Stock
NASDAQ:BOLD |
$25.63 Million | $25.63 Million | USA | $2.50 | +0.00% | -0.79% | 5.24 Million |
| 880 |
Imugene Ltd
AU:IMU |
$25.52 Million | AU$36.07 Million | Australia | AU$0.09 | +2.41% | -7.61% | 112.92 Million |
| 881 |
iBio, Inc. Common Stock
NYSE MKT:IBIO |
$24.96 Million | $24.96 Million | USA | $1.20 | -6.25% | +0.00% | 31.77 Million |
| 882 |
Radiopharm Theranostics Limited American Depositary Shares
NASDAQ:RADX |
$24.83 Million | $24.83 Million | USA | $3.15 | -1.56% | -26.57% | 2.66 Million |
| 883 |
Seoulin Bioscience Co.Ltd
KQ:038070 |
$24.62 Million | ₩36.32 Billion | Korea | ₩4115.00 | +2.62% | -6.48% | 423.13K |
| 884 |
Kainos Medicine Inc
KQ:284620 |
$24.10 Million | ₩35.56 Billion | Korea | ₩1087.00 | -8.81% | +9.58% | 8.49 Million |
| 885 |
Eutilex.Co.Ltd
KQ:263050 |
$23.94 Million | ₩35.32 Billion | Korea | ₩959.00 | +29.95% | +29.59% | 23.44 Million |
| 886 |
Tevogen Bio Holdings Inc.
NASDAQ:TVGN |
$23.80 Million | $23.80 Million | USA | $7.05 | +4.91% | +59.86% | 435.68K |
| 887 |
Evaxion Biotech AS
NASDAQ:EVAX |
$23.52 Million | $23.52 Million | USA | $2.82 | -0.35% | -7.54% | 371.17K |
| 888 |
Sareum Hldgs Plc
LSE:SAR |
$23.47 Million | £17.48 Million | UK | £23.00 | +9.52% | -2.13% | 4.79 Million |
| 889 |
Lyka Labs Limited
NSE:LYKALABS |
$23.47 Million | Rs2.17 Billion | India | Rs60.80 | +3.24% | -3.32% | 567.95K |
| 890 |
Radiopharm Theranostics Ltd
AU:RAD |
$23.43 Million | AU$33.11 Million | Australia | AU$0.01 | +0.00% | -26.32% | 100.81 Million |
| 891 |
SoftOx Solutions AS
OL:SOFTX |
$22.84 Million | Nkr217.05 Million | Norway | Nkr0.09 | +5.46% | +1.11% | 211.23 Million |
| 892 |
Aligos Therapeutics Inc
NASDAQ:ALGS |
$22.79 Million | $22.79 Million | USA | $4.23 | -2.08% | -9.81% | 5.97 Million |
| 893 |
Barinthus Biotherapeutics plc
NASDAQ:BRNS |
$22.78 Million | $22.78 Million | USA | $0.56 | +0.14% | -7.05% | 961.92K |
| 894 |
CervoMed Inc.
NASDAQ:CRVO |
$22.59 Million | $22.59 Million | USA | $2.58 | +2.38% | -3.37% | 12.44 Million |
| 895 |
Xbrane Biopharma AB
ST:XBRANE |
$22.51 Million | Skr209.14 Million | Sweden | Skr10.15 | -1.46% | +0.00% | 454.30K |
| 896 |
FibroBiologics, Inc. Common Stock
NASDAQ:FBLG |
$22.48 Million | $22.48 Million | USA | $0.70 | -2.67% | -4.83% | 2.17 Million |
| 897 |
Kadimastem Ltd
TA:KDST |
$22.18 Million | ILA8.27 Billion | Israel | ILA2794.00 | -1.13% | -8.21% | 524.25K |
| 898 |
Vyne Therapeutics Inc
NASDAQ:VYNE |
$22.03 Million | $22.03 Million | USA | $30.45 | +8.56% | +3311.00% | 39.60 Million |
| 899 |
Medivir AB
ST:MVIR |
$21.97 Million | Skr204.15 Million | Sweden | Skr1.82 | -2.88% | +7.44% | 27.85 Million |
| 900 |
Nanogroup SA
WAR:NNG |
$21.86 Million | zł79.45 Million | Poland | zł2.47 | -0.80% | -1.00% | 1.07 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries